Medication and diabetic complications

Journal articles and book chapters

10-21-2018 | Sitagliptin | Article

A randomized clinical trial to evaluate the single‐dose pharmacokinetics, pharmacodynamics and safety of sitagliptin in pediatric patients with type 2 diabetes

Fraser IP et al. Pediatr Diabetes 2018. doi: 10.1111/pedi.12790

10-16-2018 | Metabolic surgery | Article

Association between bariatric surgery and macrovascular disease outcomes in patients with type 2 diabetes and severe obesity

Fisher DP et al. JAMA 2018; 320: 1570–1582. doi: 10.1001/jama.2018.14619

10-15-2018 | Statins | Review | Article

Beyond statins: Who and when to prescribe?

Ganda O. Curr Diab Rep 2018; 18: 126. doi: 10.1007/s11892-018-1087-0

10-08-2018 | Complications | Review | Article

Diabetes and HIV

Noubissi EC, Katte JC, Sobngwi E. Curr Diab Rep 2018; 18: 125. doi: 10.1007/s11892-018-1076-3

10-08-2018 | Dapagliflozin | Article

Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure

Soga F et al. Cardiovasc Diabetol 2018; 17: 132. doi: 10.1186/s12933-018-0775-z

10-05-2018 | Hyperglycemia | Article

Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

This consensus report addresses the approaches to management of glycemia in adults with type 2 diabetes, with the goal of reducing complications and maintaining quality of life in the context of comprehensive cardiovascular risk management and patient-centered care.

10-04-2018 | Mobile technology | Review | Article

App-based insulin calculators: Current and future state

Eiland L et al. Curr Diab Rep 2018; 18: 123. doi: 10.1007/s11892-018-1097-y

09-24-2018 | Atherosclerosis | Article

Prevention of atherothrombotic events in patients with diabetes mellitus: From antithrombotic therapies to new-generation glucose-lowering drugs

Patti G et al. Nat Rev Cardiol 2018. doi: 10.1038/s41569-018-0080-2

09-14-2018 | Insulin glargine/Lixisenatide | Article

Bedtime-to-morning glucose difference and iGlarLixi in type 2 diabetes: Post hoc analysis of LixiLan-L

Zisman A et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0507-0

09-14-2018 | Psychosocial care | Article

Improved treatment engagement among patients with diabetes treated with insulin glargine 300 U/mL who participated in the COACH support program

Goldman JD et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0501-6

09-13-2018 | Pramlintide acetate | Article

Control of postprandial hyperglycemia in type 1 diabetes by 24-hour fixed-dose coadministration of pramlintide and regular human insulin: A randomized, two-way crossover study

Riddle MC et al. Diabetes Care 2018: dc181091. doi: 10.2337/dc18-1091

09-12-2018 | SGLT2 inhibitors | Article

Comparative risk of genital infections associated with SGLT2 inhibitors: A real‐world retrospective cohort study

Dave CV et al. Diabetes Obes Metab 2018. doi: 10.1111/dom.13531

09-12-2018 | Retinopathy | Article

The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: A meta-analysis

Cai X et al. Endocrine 2018. doi: 10.1007/s12020-018-1697-y

09-10-2018 | Insulin glargine | Article

Association of patient profile with glycemic control and hypoglycemia with insulin glargine 300 U/mL in type 2 diabetes: A post hoc patient-level meta-analysis

Twigg SM et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0498-x

09-08-2018 | Nephropathy | Review | Article

Metabolic abnormalities in diabetes and kidney disease: Role of uremic toxins

Koppe L, Fouque D, Soulage CO. Curr Diab Rep 2018; 18: 97. doi: 10.1007/s11892-018-1064-7

09-05-2018 | Anti-hypertensive medications | Article

Alirocumab safety in people with and without diabetes mellitus: Pooled data from 14 ODYSSEY trials

Leiter LA et al. Diabet Med 2018. doi: 10.1111/dme.13817

09-05-2018 | Older adults | Review | Article

Diabetes treatment in the elderly: Incorporating geriatrics, technology, and functional medicine

Valencia WM et al. Curr Diab Rep 2018; 18: 95. doi: 10.1007/s11892-018-1052-y

09-04-2018 | Mental health | Article

Long-term glycemic control and dementia risk in type 1 diabetes

Lacy ME et al. Diabetes Care 2018: dc180073. doi: 10.2337/dc18-0073

09-02-2018 | Atherosclerosis | Article

Early atherosclerosis is associated with retinal microvascular changes in adolescents with type 1 diabetes

Peña AS et al. Ped Diabetes 2018. doi: 10.1111/pedi.12764

08-31-2018 | Retinopathy | Article

Could intensive blood pressure control really reduce diabetic retinopathy outcomes? Evidence from meta-analysis and trial sequential analysis from randomized controlled trials

Zhou JB et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0497-y

Next Previous